Laurence C. Van Warmerdam - Publications

Retreatment of Metastatic Castration-Resistant Prostate Cancer Patients with 223Ra Therapy in Daily Practice.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: March 05, 2025

Oncologic outcomes of de-escalating axillary treatment in clinically node-positive breast cancer patients treated with neoadjuvant systemic therapy - A two center cohort study.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: April 28, 2024

Addition of zoledronic acid to neoadjuvant chemotherapy is not beneficial in patients with HER2-negative stage II/III breast cancer: 5-year survival analysis of the NEOZOTAC trial (BOOG 2010-01).

Journal: Breast cancer research : BCR

Published: April 25, 2019

Intermittent versus continuous first-line treatment for HER2-negative metastatic breast cancer: the Stop & Go study of the Dutch Breast Cancer Research Group (BOOG).

Journal: Breast cancer research and treatment

Published: July 25, 2018

Predicting breast and axillary response after neoadjuvant treatment for breast cancer: The role of histology vs receptor status.

Journal: The breast journal

Published: May 22, 2017

Ultrasound is at least as good as magnetic resonance imaging in predicting tumour size post-neoadjuvant chemotherapy in breast cancer.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 09, 2015

Bioequivalence of Liposome-Entrapped Paclitaxel Easy-To-Use (LEP-ETU) formulation and paclitaxel in polyethoxylated castor oil: a randomized, two-period crossover study in patients with advanced cancer.

Journal: Clinical therapeutics

Published: June 25, 2013

Chemotherapy and cognitive complaints in women with breast cancer.

Journal: Psycho-oncology

Published: May 10, 2012